Role of hematopoetic growth factors in the treatment of neutropenia caused by chemotherapy and radiotherapy of cancer

Janusz Skowronek

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/1999
vol. 3

Send email

Copy url:

abstract:

Role of hematopoetic growth factors in the treatment of neutropenia caused by chemotherapy and radiotherapy of cancer

Janusz Skowronek

Współcz Onkol (1999) 4, 152-153

Online publish date: 2003/08/05

View full text Get citation

Granulocyte, macrophage colony stimulating factor (GM-CSF) is one of the well recognised cytokines involved in the regulation of hematopoiesis. GM-CSF has demonstrated efficacy in decreasing the duration of neutropenia, decreasing the attendant infection, and enhancing the ability to deliver full doses of myelosuppressive therapy and continuation of radiotherapy. GM-CSF can also reverse the neutropenia of myelodysplastic syndrome and aplastic anemia.

In this paper the GM-CSF and possibilities of its application in the treatment of neutropenia inducted by chemotherapy and radiotherapy and in the treatment of some diseases of the hematopoietic system are presented.

keywords:

Role of hematopoetic growth factors in the treatment of neutropenia caused by chemotherapy and radiotherapy of cancer

Janusz Skowronek

GM-CSF, molgramostin, neutropenia, chemotherapy, radiotherapy